Seven Springs Wealth Group’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-250
Closed -$16K 85
2021
Q1
$16K Hold
250
0.01% 110
2020
Q4
$16K Hold
250
0.01% 109
2020
Q3
$15K Hold
250
0.01% 106
2020
Q2
$15K Hold
250
0.01% 104
2020
Q1
$14K Sell
250
-215
-46% -$13.1K 0.01% 103
2019
Q4
$30K Buy
+465
New +$26.6K 0.02% 112

Other funds holding BMY

Seven Springs Wealth Group's BMY Position: Q2 2021 in Review

Seven Springs Wealth Group sold out of Bristol-Myers Squibb (BMY) in Q2 2021, closing a stake of 250 shares — an estimated $16K sold.

Seven Springs Wealth Group first reported a position in BMY in Q4 2019 and held it in 6 quarters. The position peaked at $30K in Q4 2019. 2,369 funds tracked by Wall St. Rank hold BMY as of Q2 2021.

  • Seven Springs Wealth Group reported no remaining Bristol-Myers Squibb position as of Q2 2021 after selling out during the quarter.
  • Seven Springs Wealth Group sold 250 Bristol-Myers Squibb shares in Q2 2021, an estimated $16K.
  • Seven Springs Wealth Group first reported a position in Bristol-Myers Squibb in Q4 2019 and held it in 6 quarters.
  • Seven Springs Wealth Group's Bristol-Myers Squibb position peaked at $30K in Q4 2019.
  • 2,369 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2021.

Based on Seven Springs Wealth Group's 13F filing for Q2 2021, filed 27 Jul 2021.